Abstract
Multiple myeloma (MM) may be preceded by a monoclonal gammopathy of undetermined significance (MGUS), but it is at present unclear whether or not MM post-MGUS is biologically and clinically different from MM de-novo. To address this issue, we have performed a molecular cytogenetic analysis of 32 cases of MM post-MGUS (median time between recognition of MGUS and transition to MM, 7.6 years; range, 2.6 years to 19.5 years) and compared the findings with those of 256 patients with MM de-novo, in whom no previous history of MGUS had been documented. FISH studies of clonal plasma cells (cytoplasmic Ig positive) with probes for IgH translocations [t(14q32)], t(11;14)(q13;q32), t(4;14)(p16;q32), and deletion of 13q14 [del(13q14)] revealed results summarized in Table 1:
Serial studies of MGUS plasma cells and MM post-MGUS plasma cells from 12 of these patients have thus far indicated that all chromosomal abnormalities observed at MM post-MGUS were already present in the MGUS plasma cells; most notably, there was one patient with t(4;14) plus del(13q) who had both abnormalities at the time of MGUS 94 months prior to transition to MM. Collectively, our data suggest that MM post-MGUS is characterized by a distinct chromosomal pattern, in particular a high frequency of t(14q32) plus del(13q14), frequent occurrence of a t(11;14), but low frequency of a t(4;14). We are currently studying the t(14q32) plus del(13q) chromosomal pattern in MGUS to investigate its potential value as a risk factor for transition from MGUS to MM.
Table 1: FISH of MM post-MGUS versus MM de novo
Abnormality . | MM post-MGUS . | MM de-novo . | P-value . |
---|---|---|---|
Any t(14q32) | 24/32 (75%) | 114/256 (44.5%) | .05 |
t(11;14)(q13;q32) | 9/32 (28.1%) | 32/256 (12.5%) | .05 |
t(4;14)(p16;q32) | 2/32 (6.3%) | 27/256 (10.6%) | .37 |
del(13q14) | 19/32 (59.4%) | 102/256 (39.8%) | .13 |
del(13q14) plus t(14q32) | 18/19 (94.7%) | 57/102 (55.8%) | .11 |
del(13q14) plus t(11;14) | 6/19 (31.6%) | 9/102 (8.8%) | .03 |
Abnormality . | MM post-MGUS . | MM de-novo . | P-value . |
---|---|---|---|
Any t(14q32) | 24/32 (75%) | 114/256 (44.5%) | .05 |
t(11;14)(q13;q32) | 9/32 (28.1%) | 32/256 (12.5%) | .05 |
t(4;14)(p16;q32) | 2/32 (6.3%) | 27/256 (10.6%) | .37 |
del(13q14) | 19/32 (59.4%) | 102/256 (39.8%) | .13 |
del(13q14) plus t(14q32) | 18/19 (94.7%) | 57/102 (55.8%) | .11 |
del(13q14) plus t(11;14) | 6/19 (31.6%) | 9/102 (8.8%) | .03 |
Author notes
Corresponding author